Galera Therapeutics Inc. (GRTX) - Insider Holders & Insider Ownership

List of insiders holdings for Galera Therapeutics Inc.:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
#Insider Holder NameReport
Date Time		Shares Owned
Directly
Indirectly		Total
Shares Owned		Filing
1Schneid Yair
10% Owner		2024-05-16 10:26:1710,823,610
0		10,823,610Form 13G
2Soffer Rochel
ALPHA PHARMA Investments LLC
10% Owner		2024-05-16 10:26:453,178,137
2,750,000		5,928,137Form 3
3New Enterprise Associates 14 L.P.
Sonsini Peter W.
KERINS PATRICK J
NEA Partners 14 L.P.
NEA 14 GP LTD
BARRIS PETER J
BASKETT FOREST
Florence Anthony A. Jr.
MOTT DAVID M
SANDELL SCOTT D
10% Owner		2020-02-13 10:50:024,358,042
0		4,358,042Form 13G
4Blackstone Clarus GP L.P.
Blackstone Clarus GP L.L.C.
Blackstone Holdings II L.P.
Blackstone Holdings I/II GP L.L.C.
Blackstone Group Inc
Blackstone Group Management L.L.C.
SCHWARZMAN STEPHEN A
10% Owner		2023-12-04 16:32:022,289,605
0		2,289,605Form 13D
5Novo Holdings A/S
10% Owner		2023-06-28 16:19:562,100,000
0		2,100,000Form 13G
6Sussman Joel F.
Chief Accounting Officer		2025-05-05 16:19:432,000,000
0		2,000,000Form 4
7Novartis Bioventures Ltd
NOVARTIS AG
Former 10% Owner		2022-02-11 16:30:53476,085
0		476,085Form 13G
8Sorensen Mel
President and CEO		2025-11-24 16:42:45195,029
0		195,029Form 4
9Keene Jeffrey
10% Owner		2019-11-06 17:27:59172,238
0		172,238Form 3
10Beardsley Robert A
Chief Operating Officer		2023-02-28 19:06:09135,000
0		135,000Form 4
11Stacey Jennifer Evans
See Remarks		2023-02-28 18:56:05135,000
0		135,000Form 4
12Clarus IV-A L.P.
Clarus IV-B L.P.
Clarus IV-C L.P.
Clarus IV-D L.P.
Clarus IV GP L.P.
10% Owner		2019-11-14 17:00:590
130,444		130,444Form 4
13FRIEDMAN MICHAEL R.
Director		2025-02-26 16:52:5796,000
0		96,000Form 4
14CHANG NANCY T
Director
10% Owner		2025-02-26 16:46:2296,000
0		96,000Form 4
15Fratamico Arthur
Chief Business Officer		2021-01-28 16:05:0975,000
0		75,000Form 4
16HOLMLUND JON T
Chief Medical Officer		2022-03-02 16:05:4675,000
0		75,000Form 4
17Matthes Catherine L.
10% Owner		2019-11-06 17:24:248,503
66,184		74,687Form 3
18Riley Dennis
Chief Scientific Officer		2020-02-04 18:00:4374,435
0		74,435Form 4
19POWELL MICHAEL
Director		2023-06-16 16:15:3564,000
0		64,000Form 4
20Buckler Regina A.
10% Owner		2019-11-06 17:28:5462,254
0		62,254Form 3
21Wood Brian
10% Owner		2019-11-06 17:32:3462,137
0		62,137Form 3
22Brill Jeffrey
10% Owner		2019-11-06 17:31:5162,137
0		62,137Form 3
23Schall Otto
10% Owner		2019-11-06 17:20:1055,137
0		55,137Form 3
24Kennedy Eugene P.
Chief Medical Officer		2023-02-28 18:57:3455,000
0		55,000Form 4
25LOKAY KEVIN G
Director		2025-02-26 16:57:1148,000
0		48,000Form 4
26Alleva Lawrence M
Director		2025-02-26 16:43:3848,000
0		48,000Form 4
27Ross Stephen A
10% Owner		2019-11-06 17:21:5846,622
0		46,622Form 3
28West Linda
Director		2023-07-05 16:11:0223,382
0		23,382Form 4
29Fuller Jason
Director		2019-11-08 19:49:1319,776
0		19,776Form 4
30Bachleda Mark
Chief Commercial Officer		2023-03-20 16:05:1711,000
0		11,000Form 4
31Degnan Chris
Chief Financial Officer		2023-03-14 08:30:0910,000
0		10,000Form 4
32Altamont Pharmaceutical Holdings LLC
Pearson Mark E.
10% Owner		2024-04-03 08:08:380
0		0Form 13G
33Cunningham Emmett
Director		2023-06-16 16:15:100
0		0Form 4
34Sofinnova Venture Partners IX L.P.
Sofinnova Management IX L.L.C.
POWELL MICHAEL
HEALY JAMES
Mehra Anand
10% Owner		2024-02-20 18:57:580
0		0Form 13D